Different interpretation of additional evidence for HTA by the commissioned HTA body and the commissioning decision maker in Germany: whenever IQWiG and Federal Joint Committee disagree

MLA

C. M. Dintsios, et al. “Different Interpretation of Additional Evidence for HTA by the Commissioned HTA Body and the Commissioning Decision Maker in Germany: Whenever IQWiG and Federal Joint Committee Disagree.” Health Economics Review, vol. 9, no. 1, Dec. 2019, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s13561-019-0254-6.

APA

C. M. Dintsios, F. Worm, J. Ruof, & M. Herpers. (2019). Different interpretation of additional evidence for HTA by the commissioned HTA body and the commissioning decision maker in Germany: whenever IQWiG and Federal Joint Committee disagree. Health Economics Review, 9(1), 1–15. https://doi.org/10.1186/s13561-019-0254-6

Chicago

C. M. Dintsios, F. Worm, J. Ruof, and M. Herpers. 2019. “Different Interpretation of Additional Evidence for HTA by the Commissioned HTA Body and the Commissioning Decision Maker in Germany: Whenever IQWiG and Federal Joint Committee Disagree.” Health Economics Review 9 (1): 1–15. doi:10.1186/s13561-019-0254-6.